MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Summit Therapeutics PLC Company Profile (LON:SUMM)

Consensus Ratings for Summit Therapeutics PLC (LON:SUMM) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Summit Therapeutics PLC (LON:SUMM)
Show:
DateFirmActionRatingPrice TargetActions
8/28/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2015JMP SecuritiesInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/4/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/30/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014N+1 SingerReiterated RatingCorporateView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2014N+1 SingerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2013N+1 SingerReiterated RatingBuyGBX 16View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2013N+1 SingerBoost Price TargetBuyGBX 11 -> GBX 16.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/1/2013N+1 SingerReiterated RatingBuyGBX 11View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/31/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha